Efficacy and safety of combined piroxicam, dexamethasone, orphenadrine, and cyanocobalamin treatment in mandibular molar surgery

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 9, 2006, Pages 1241-1247

  Barroso, A B ^a   Lima, V ^a   Guzzo, G C ^a   Moraes, R A ^a   Vasconcellos, M C ^a   Bezerra, M M ^a   Viana, F A L ^a   Bezerra, R C R ^a   Santana, G S M ^a   Frota Bezerra, F A ^a   Moraes, M O ^a   Moraes, M E A ^a,b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Cyanocobalamin; Dexamethasone; Mandibular molar surgery; Orphenadrine; Pain; Piroxicam

Indexed keywords

CYANOCOBALAMIN; DEXAMETHASONE; MEPIVACAINE; ORPHENADRINE; PARACETAMOL; PIROXICAM; RHEUMAZIN;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; FACE EDEMA; FEMALE; FEVER; HEADACHE; HUMAN; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARESTHESIA; PATIENT SATISFACTION; POSTOPERATIVE PAIN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SOMNOLENCE; STATISTICAL SIGNIFICANCE; STOMACH DISEASE; STOMACH PAIN; TOOTH EXTRACTION; VISUAL ANALOG SCALE;

EID: 33750009882     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000900012     Document Type: Article

References (33)

1. Barden J, Edwards JE, McQuay HJ, Andrew MR. Pain and analgesic response after third molar extraction and other postsurgical pain. Pain 2004; 107: 86-90.
2. Khan AA, Brahim JS, Rowan JS, Dionne RA. In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. Clin Pharmacol Ther 2002; 72: 44-49.
3. Desjardins PJ. Analgesic efficacy of piroxicam in postoperative dental pain. Am J Med 1988; 84: 35-41.
4. Vane J, Botting R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1987; 1: 89-96.
5. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol Suppl 1996; 102: 9-21.
6. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004; 28: 140-175.
7. Pittock SJ, Payne TA, Harper CM. Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. Mayo Clin Proc 2002; 77: 291-294.
8. Hillman RS. Hematopoietic agents: growth factors, minerals, and vitamins. In: Hardman JG, Limbird LE, Gilman AG (Editors), Goodman and Gilman's the pharmacological basis of therapeutics. 10th edn. New York: McGraw Hill; 2001. p 1487-1517.
9. Patel A, Skelly AM, Kohn H, Preiskel HW. Double-blind placebo-controlled comparison of the analgesic effects of single doses of lornoxicam and aspirin in patients with postoperative dental pain. Br Dent J 1991; 170: 295-299.
10. Susarla SM, Dodson TB. Estimating third molar extraction difficulty: a comparison of subjective and objective factors. J Oral Maxillofac Surg 2005; 63: 427-434.
11. Garcia AG, Sampedro FG, Rey JG, Vila PG, Martin MS. Pell-Gregory classification is unreliable as a predictor of difficulty in extracting impacted lower third molars. Br J Oral Maxillofac Surg 2000; 38: 585-587.
12. Walton GM, Rood JP, Snowdon AT, Rickwood D. Ketorolac and diclofenac for postoperative pain relief following oral surgery. Br J Oral Maxillofac Surg 1993; 31: 158-160.
13. Hyrkas T, Ylipaavalniemi P, Oikarinen VJ, Paakkari I. A comparison of diclofenac with and without single-dose intravenous steroid to prevent postoperative pain after third molar removal. J Oral Maxillofac Surg 1993; 51: 634-636.
14. O'Brien TP, Roszkowski MT, Wolff LF, Hinrichs JE, Hargreaves KM. Effect of a non-steroidal anti-inflammatory drug on tissue levels of immunoreactive prostaglandin E2, immunoreactive leukotriene, and pain after periodontal surgery. J Periodontol 1996; 67: 1307-1316.
15. Olmedo MV, Vallecillo M, Gálvez R. Relación de las variables del paciente y de la intervención con el dolor y la inflamación postoperatorios en la exodoncia de los terceros molares. Med Oral 2002; 7: 360-369.
16. Roszkowski MT, Swift JQ, Hargreaves KM. Effect of NSAID administration on tissue levels of immunoreactive prostaglandin E2, leukotriene B4, and (S)-flurbiprofen following extraction of impacted third molars. Pain 1997; 73: 339-345.
17. Hart FD, Huskisson EC. Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use. Drugs 1984; 27: 232-255:
18. Ferreira SH. Peripheral analgesic sites of action of anti-inflammatory drugs. Int J Clin Pract Suppl 2002; 2-10.
19. Gersema L, Baker K. Use of corticosteroids in oral surgery. J Oral Maxillofac Surg 1992; 50: 270-277.
20. Montgomery MT, Hogg JP, Roberts DL, Redding SW. The use of glucocorticosteroids to lessen the inflammatory sequelae following third molar surgery. J Oral Maxillofac Surg 1990; 48: 179-187.
21. Kaitin KI, Manocchia M, Seibring M, Lasagna L. The now drug approvals of 1990, 1991, and 1992: trends in drug development. J Clin Pharmacol 1994; 34: 120-127.
22. Schultze-Mosgau S, Schmelzeisen R, Frolich JC, Schmele H. Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars. J Oral Maxillofac Surg 1995; 53: 2-7.
23. Hirschelmann R, Poch G, Rafler I, Rickinger O, Giessier J. Steroid-saving potency of nonsteroidal antiinflammatory agents - a reevaluation with the new agent CGP 28238 in rat inflammatory models. Agents Actions Suppl 1991; 32: 51-57.
24. Golikov PP, Nikolaeva NI, Marchenko, VV. Nonsteroidal antiinflammatory agents as modulators of glucocorticoid function of receptors. Vestn Ross Akad Med Nauk 1994; 47-52.
25. Stewart R, Bill R, Ullah R, McConaghy P, Hall SJ. Dexamethasone reduces pain after tonsillectomy in adults. Clin Otolaryngol Allied Sci 2002; 27: 321-326.
26. Meredith TJ, Vale JA. Non-narcotic analgesics. Problems of over-dosage. Drugs 1986; 32 (Suppi 4): 177-205.
27. Goppelt-Struebe M. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem Pharmacol 1997; 53: 1389-1395.
28. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 1995; 43: 227-235.
29. Hunskaar S, Donnell D. Clinical and pharmacological review of the efficacy of orphenadrine and its combination with paracetamol in painful conditions. J Int Med Res 1991; 19: 71-87.
30. Troullos ES, Hargreaves KM, Butler DP, Dionne RA. Comparison of nonsteroidal anti-inflammatory drugs, ibuprofen and flurbiprofen, with methylprednisolone and placebo for acute pain, swelling, and trismus. J Oral Maxillofac Surg 1990; 48: 945-952.
31. Clark AJ, McLoughlin L, Grossman A. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 1993; 341: 461-462.
32. Weissbach H, Taylor RT. Metabolic role of vitamin B12. Vitam Horm 1968; 26: 395-412.
33. Watanabe T, Kaji R, Oka N, Bara W, Kimura J. Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy. J Neurol Sci 1994; 122: 140-143.